Cargando…
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Diabetic cardiomyopathy (DCM) mainly refers to myocardial metabolic dysfunction caused by high glucose, and hyperglycemia is an independent risk factor for cardiac function in the absence of coronary atherosclerosis and hypertension. DCM, which is a severe complication of diabetes, has become the le...
Autores principales: | Huo, Jin-Ling, Feng, Qi, Pan, Shaokang, Fu, Wen-Jia, Liu, Zhangsuo, Liu, Zhenzhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362058/ https://www.ncbi.nlm.nih.gov/pubmed/37479697 http://dx.doi.org/10.1038/s41420-023-01553-4 |
Ejemplares similares
-
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009) -
Catecholamine cardiomyopathy: review and analysis of pathogenetic mechanisms.
por: Jiang, J. P., et al.
Publicado: (1990) -
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
por: Scioli, Maria Giovanna, et al.
Publicado: (2020) -
MicroRNA Dysregulation in Epilepsy: From Pathogenetic Involvement to Diagnostic Biomarker and Therapeutic Agent Development
por: Wang, Jialu, et al.
Publicado: (2021) -
Concise review: current trends on applications of stem cells in diabetic nephropathy
por: Liu, Dongwei, et al.
Publicado: (2020)